Cours Peloton Therapeutics, Inc.
Actions
PLTX
US70614L1044
Recherche biotechnologique et médicale
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Naseem Zojwalla
CTO | Chief Tech/Sci/R&D Officer | 51 | - |
Corporate Officer/Principal | - | - | |
Peter Stenge
PRN | Corporate Officer/Principal | - | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Helen Kim
BRD | Director/Board Member | 61 | 01/11/17 |
Brett A. Ringle
BRD | Director/Board Member | 73 | 01/01/11 |
David Chang
BRD | Director/Board Member | 64 | 01/02/18 |
Varia. 1 janv. | Capi. | |
---|---|---|
+11,91% | 118 Md | |
+11,60% | 106 Md | |
-4,68% | 24,28 Md | |
-0,82% | 21,96 Md | |
-10,12% | 18,16 Md | |
-42,12% | 16,37 Md | |
-17,47% | 15,56 Md | |
+2,77% | 13,63 Md | |
+34,58% | 12,27 Md |